Hillman Co. continued to hold its stake in RTI Surgical Inc. (NASDAQ:RTIX) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,682,874 shares of the company’s stock at the end of the second quarter. RTI Surgical makes up 4.8% of Hillman Co.’s portfolio, making the stock its 8th largest position. Hillman Co. owned approximately 4.64% of RTI Surgical worth $9,632,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in RTIX. Renaissance Technologies LLC boosted its stake in RTI Surgical by 27.0% in the first quarter. Renaissance Technologies LLC now owns 326,700 shares of the company’s stock worth $1,307,000 after buying an additional 69,500 shares in the last quarter. Royce & Associates LP boosted its stake in RTI Surgical by 4.3% in the first quarter. Royce & Associates LP now owns 1,626,234 shares of the company’s stock worth $6,505,000 after buying an additional 67,460 shares in the last quarter. Landscape Capital Management L.L.C. purchased a new stake in RTI Surgical during the first quarter worth about $269,000. Gagnon Securities LLC boosted its stake in RTI Surgical by 21.1% in the first quarter. Gagnon Securities LLC now owns 262,950 shares of the company’s stock worth $1,052,000 after buying an additional 45,830 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in RTI Surgical by 65.5% in the first quarter. Goldman Sachs Group Inc. now owns 58,132 shares of the company’s stock worth $233,000 after buying an additional 23,017 shares in the last quarter. Institutional investors and hedge funds own 78.99% of the company’s stock.

Shares of RTI Surgical Inc. (NASDAQ:RTIX) traded down 1.62% during mid-day trading on Tuesday, reaching $3.03. The company’s stock had a trading volume of 65,083 shares. The firm has a 50 day moving average price of $3.21 and a 200 day moving average price of $3.69. RTI Surgical Inc. has a 52-week low of $2.81 and a 52-week high of $6.26. The firm has a market cap of $175.05 million, a price-to-earnings ratio of 42.68 and a beta of 1.44.

RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings data on Wednesday, July 27th. The company reported ($0.05) EPS for the quarter, missing the Zacks’ consensus estimate of $0.03 by $0.08. RTI Surgical had a return on equity of 6.51% and a net margin of 2.80%. The company had revenue of $67.60 million for the quarter, compared to the consensus estimate of $66.52 million. During the same quarter last year, the business earned $0.04 EPS. RTI Surgical’s revenue was down 5.6% on a year-over-year basis. On average, equities analysts predict that RTI Surgical Inc. will post $0.10 EPS for the current fiscal year.

A number of brokerages have weighed in on RTIX. Craig Hallum cut RTI Surgical from a “buy” rating to a “hold” rating and lowered their price target for the company from $6.00 to $4.00 in a research report on Thursday, July 28th. Zacks Investment Research cut RTI Surgical from a “hold” rating to a “sell” rating in a research report on Friday, July 29th.

About RTI Surgical

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

5 Day Chart for NASDAQ:RTIX

Want to see what other hedge funds are holding RTIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTI Surgical Inc. (NASDAQ:RTIX).

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.